← Back to all earnings calls

Akebia Therapeutics, Inc. Q2 FY2026 Earnings Call

Akebia Therapeutics, Inc. (AKBA)

Earnings Call FY2026 Q2 Call date: 2026-08-05 Concluded

Share

Quarter scorecard

Revenue

$49.13M

-21.4% YoY

Diluted EPS

$-0.03

Net income

-$8.91M

-3706.5% YoY

Documents & deck